Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk

Key Points

• The aim is to compare mortality risks in younger patients with favorable intermediate-risk prostate cancer under different management strategies.
• Analyzed data from patients aged under 60 with favorable intermediate-risk prostate cancer.
• Compared outcomes between active surveillance/watching and treatment options like radical prostatectomy or radiation therapy.
• Considered the impact of race on management outcomes.
• Mortality risks were low and comparable between patients managed with active surveillance/watching and those treated.
• No significant differences in early mortality risks based on race.